Granules Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRANULES, and what generic and branded alternatives to GRANULES drugs are available?
GRANULES has sixty-two approved drugs.
There is one tentative approval on GRANULES drugs.
Summary for Granules
US Patents: | 0 |
Tradenames: | 49 |
Ingredients: | 49 |
NDAs: | 62 |
Patent Litigation for Granules: | See patent lawsuits for Granules |
Drugs and US Patents for Granules
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Granules | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 218015-001 | Sep 29, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Granules | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 214039-001 | Feb 23, 2021 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Granules | DOFETILIDE | dofetilide | CAPSULE;ORAL | 212750-001 | Oct 14, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Granules | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 218015-002 | Sep 29, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.